Biosynex SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 142.2 million compared to EUR 225.2 million a year ago. Net income was EUR 30.6 million compared to EUR 70.5 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 EUR | -1.59% |
|
-7.05% | -62.87% |
28/05 | Biosynex: obtains CE markings under the new IVDR regulations | CF |
13/05 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
1st Jan change | Capi. | |
---|---|---|
-62.87% | 36.29M | |
-11.33% | 11.41B | |
-12.48% | 7.4B | |
+31.15% | 5.64B | |
-0.32% | 5.33B | |
-18.68% | 3.7B | |
+7.43% | 2.58B | |
-64.53% | 2.38B | |
+27.01% | 2.2B | |
-10.53% | 2.2B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2022